MBS unveils NEXTGENPCR revolution in thermal cycling at Festival of Genomics
Rotterdam, Netherlands, Feb 1, 2017: Dutch biotechnology company Molecular Biology Systems(MBS) today unveiled the pre-production model of its revolutionary new NEXTGENPCR thermal cycler at the Festival of Genomics in London. Described as the first real advance in thermal cycling for 15 years, the NEXTGENPCR dramatically reduces current time consuming DNA amplification from hours to minutes. As an example, Erasmus Medical Centre in the Netherlands recently reported having successfully amplified the complete BRCA1 gene (29 fragments) in less then 10 minutes using NEXTGENPCR.
Read article: MBS 01_17 30.01_17 FINAL